|
Real-time Estimate
Cboe BZX
09:33:12 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 58.91 USD | +2.47% |
|
+1.52% | -3.26% |
| 12:57am | GC Biopharma Licenses Next-Generation Fabry Disease Therapy to BioMarin in $237.5 Million Deal | MT |
| 10-29 | BioMarin Signs License Deal for Fabry Disease Therapy Candidate | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BMRN | Delayed | |
London S.E.
| 0HNC | Delayed | |
|
CBOE
| BMRN | Real-time | |
|
Wiener Boerse
| BMRN | End-of-day quote | |
|
Tradegate
| BM8 | Real-time | |
|
Boerse Muenchen
| BM8 | Real-time | |
|
Deutsche Boerse AG
| BM8 | Delayed | |
|
Berne S.E.
| BM8 | End-of-day quote | |
|
Mexican S.E.
| BMRN * | End-of-day quote | |
|
Börse Stuttgart
| BM8 | Delayed | |
|
Borsa Italiana
| 1BMRN | End-of-day quote | |
Sao Paulo
| B1MR34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 59.46 | 70.24 | 67.36 |
| Spread/Res. | -3.31% | -18.15% | -14.65% |
| Spread/Supp. | +5.72% | +15.74% | +10.96% |
| Support | 54.38 | 49.67 | 51.81 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BMRN Stock
- Charts BioMarin Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
